The Rogel Cancer Center’s Pathways Undergraduate Fellowship program launched in 2022 to fill a gap in training programs that left out undergraduate students from across Michigan. Pathways is aimed at students from Michigan universities excluding U-M’s Ann Arbor campus. It’s for students who might have some interest in careers in science or cancer but who aren’t fully committed.
Rogel Cancer Center faculty and trainees will lead two dozen presentations, posters and moderated sessions at the American Society for Clinical Oncology annual meeting. This year’s meeting will be held in-person and online. View the schedule of presentations and poster sessions.
Rogel Cancer Center researcher Kyoung Eun Lee, Ph.D., assistant professor of pharmacology at Michigan Medicine, has received a new $1.4 million grant from the National Cancer Institute to study the stroma and in particular how low oxygen conditions, or hypoxia, in pancreatic cancer alters the tumor-stroma interaction – and how to capitalize on that to target potential new treatments.
Researchers at the University of Michigan Rogel Cancer Center have discovered a new nutrient source that pancreatic cancer cells use to grow. The molecule, uridine, offers insight into both biochemical processes and possible therapeutic pathways.
In an invited review article recently published in the medical journal, “Current Opinion in Clinical Nutrition and Metabolic Care,” Research Professor Zora Djuric, Ph.D. of the Department of Family Medicine found that by including more fiber, plant-based foods, omega-3 fatty acids and whole grains, people can mitigate the adverse health effects of high fat diets and obesity on their microbiome.
Researchers at the University of Michigan Rogel Cancer have received a $2 million grant from the National Cancer Institute to understand the role myeloid cells play in how pancreatic cancer develops and progresses.
Professor Diane Harper, MD, MPH, MS, of the Department of Family Medicine, has been elected to the Association of American Physicians (AAP). She was inducted at a formal ceremony on Saturday, April 22, 2023, in Chicago.
Andrew Shuman, M.D., FACS, HEC-C, chief of the clinical ethics service in Michigan Medicine’s Center for Bioethics and Social Sciences, recently testified before the Homeland Security and Governmental Affairs Committee for the United States Senate regarding critical drug shortages.
Rogel researchers get $3 million to improve survivorship care for younger colorectal cancer patients
A team of University of Michigan Rogel Cancer Center researchers have received a $3.07 million grant from the National Cancer Institute to develop a model for long-term surveillance and care of younger adults treated for colorectal cancer.
Michelle Kim, M.D., associate professor of radiation oncology at Michigan Medicine, has received a Research Specialist Award from the National Cancer Institute to pursue clinical research efforts at the University of Michigan Rogel Cancer Center and nationally. Kim’s focus is on clinical research for central nervous system (CNS) tumors.